INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![Obesity Clinical Trials Beyond BMI]( "Obesity Clinical Trials: Beyond BMI")
Obesity Clinical Trials: Beyond BMIDiscover how new approaches can improve patient assessment, enable precision medicine, and help address key challenges in developing effective obesity therapies.
-
![patient-voice-mental-health-GettyImages-1975794314]( "Turning Innovation Into Execution In CNS Trials")
Turning Innovation Into Execution In CNS TrialsSCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.
-
![business analytics, data management, strategy-GettyImages-1408832606]( "Investigator Databank And DQS: Welcoming New Consortium Members")
Investigator Databank And DQS: Welcoming New Consortium MembersJoin the Data Query System consortium to access a comprehensive, collaborative platform that enhances clinical trial feasibility, site selection, and investigator engagement.
-
![clinical-trials-site-paymentGettyImages-1959739742]( "Do You Know Today, What Your Trial Will Spend Tomorrow?")
Do You Know Today, What Your Trial Will Spend Tomorrow?Fragmented data and outdated forecasting can derail trial budgets. Real-time financial and operational insights improve accuracy and spending control.
-
Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials4/6/2026
Reclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.
-
Harnessing AI for Pre-Award Landscape Analysis And Site Selection1/16/2026
AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.
-
Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy9/25/2025
Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.
-
Delivering Complex Oncology Trials At Scale5/19/2026
Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.
-
Transforming Clinical Trial Sites With Research Study Rockstar2/10/2025
This innovative platform streamlines workflows, automates patient communication, and provides intuitive dashboards to address prevalent pain points faced by trial coordinators.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-904483784 doctor patient]( "Clinical Trial Site Selection And Management")
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
![GettyImages-911404660-driving-car-road]( "Remove This Top Barrier And Stop Losing Clinical Trial Participants")
Comprehensive travel and concierge support removes barriers to clinical trial participation, easing burdens for patients and sites while boosting retention and research outcomes.
-
![GettyImages-1390380585 business, meeting, data, research, office]( "Empower Your Research Sites With A Full-Service Marketing Solution")
Built for Sites, Not Just Sponsors
Too many recruitment vendors focus solely on the sponsor’s bottom line, leaving sites stuck managing clunky spreadsheets, manual tracking, and outreach tasks without the infrastructure to scale.
-
![GettyImages-1467006387 doctor at computer]( "Forecast And Budget Investigator Grants Confidently")
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.
-
![doctor and patient consultation-GettyImages-2101007339]( "Clinical Safety Services In FSP Models")
Selecting the right functional service provider (FSP) for safety services is fundamental to protecting patients and requires a resilient, strategic partnership that enhances trial integrity and outcomes.
